Product Manager Torbjörn Norberg will, from 1 January 2020, assume responsibility for innovation and research from current Research Manager Hans Dahlin. Hans will continue to serve as advisor to CEO Mats Högberg and Product Manager Torbjörn Norberg.
Torbjörn Norberg has a PhD in Molecular Biology from the Karolinska Institutet in the field of experimental oncology. Torbjörn has over 10 years of academic research experience and 25 years of experience in running early industrial development projects. Torbjörn will now lead, in parallel with his role as Product Manager, the ongoing innovation projects in Pharmacologs, of which the antibiotic project with Uppsala University and the Academic Hospital is what has come the longest. Hans Dahlin, head of Research and Innovation, will leave his operational role at the company at his own request, but will continue to act as advisor to the CEO, Mats Högberg and Product Manager Torbjörn Norberg.
Mats Högberg, CEO, comments: “Torbjörn has a very relevant background to take over our ongoing projects and will also have a leading role in the company’s visionary work in the future. At the same time, we are grateful to continue to be able to consult with Hans after leaving his operational role in the company. As a founder, he is part of the company’s soul and has many interesting ideas for future solutions in order to improve and streamline treatment with intravenous medicines. Hans is a true visionary and has always been passionate about improving care and increasing patient safety. I have worked with Hans now and then since the early nineties and am very fascinated by his drive and ability to see solutions where others see problems.”
For more information contact:
Mats Högberg, CEO
Phone: +46 70-546 50 21
About Pharmacolog AB
Pharmacolog is specialized in developing systems and solutions for more effective and safer use of intravenous drugs. The company’s first product, DrugLog®, enables a nurse or pharmacist to quickly and easily verify that an injectable drug has the right identity and concentration. Pharmacolog’s long-term vision is an individually optimized medication for each individual patient, considering all available parameters in the control and distribution of the drug. Further information regarding the company is available at http://www.pharmacolog.com. The company’s Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.
Download as PDF